AngioDynamics, Inc.  

(Public, NASDAQ:ANGO)   Watch this stock  
Find more results for ango
17.02
+0.09 (0.53%)
After Hours: 17.02 0.00 (0.00%)
Sep 28, 4:58PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 16.75 - 17.17
52 week 9.71 - 17.54
Open 16.89
Vol / Avg. 205,044.00/148,891.00
Mkt cap 617.59M
P/E     -
Div/yield     -
EPS -1.20
Shares 36.80M
Beta 1.04
Inst. own 70%
Oct 26, 2016
AngioDynamics Inc Annual Shareholders Meeting (Estimated) - 2:00PM EDT - Add to calendar
Oct 25, 2016
AngioDynamics Inc Annual Shareholders Meeting - 2:00PM EDT - Add to calendar
Oct 5, 2016
Q1 2017 AngioDynamics Inc Earnings Release - 9:30AM EDT - Add to calendar
Oct 5, 2016
Q1 2017 AngioDynamics Inc Earnings Call - 8:00AM EDT - Add to calendar
Sep 13, 2016
AngioDynamics Inc at Morgan Stanley Global Healthcare Conference
Aug 10, 2016
AngioDynamics Inc at Canaccord Genuity Growth Conference - Webcast
Jul 13, 2016
Q4 2016 AngioDynamics Inc Earnings Release
Jul 13, 2016
Q4 2016 AngioDynamics Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q2 (May '16) 2016
Net profit margin -46.06% -12.32%
Operating margin -4.33% 0.29%
EBITD margin - 12.06%
Return on average assets -23.35% -5.81%
Return on average equity -32.68% -8.28%
Employees 1,300 -
CDP Score - -

Address

14 Plaza Dr
LATHAM, NY 12110-2166
United States - Map
+1-518-7981215 (Phone)
+1-518-7951401 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

Officers and directors

Howard W. Donnelly Independent Chairman of the Board
Age: 54
Bio & Compensation  - Reuters
James C. Clemmer President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Michael Greiner Chief Financial Officer, Executive Vice President
Age: 43
Bio & Compensation  - Reuters
Gary Barrett Senior Vice President,Quality and Regulatory Affairs
Age: 47
Bio & Compensation  - Reuters
Ben Davis Senior Vice President, Business Development
Age: 51
Bio & Compensation  - Reuters
Barbara Kucharczyk Senior Vice President-Global Operations
Age: 42
Bio & Compensation  - Reuters
Mark A. Stephens Senior Vice President - Administration
Age: 47
Bio & Compensation  - Reuters
Stephen A. Trowbridge Senior Vice President, General Counsel
Age: 41
Bio & Compensation  - Reuters
David F. Burgstahler Independent Director
Age: 47
Bio & Compensation  - Reuters
Jeffrey G. Gold Independent Director
Age: 67
Bio & Compensation  - Reuters